Authors: Fountzilas, G Tsavdaridis, D Kalogera-Fountzila, A Christodoulou, C Timotheadou, E Kalofonos, C Kosmidis, P Adamou, A Papakostas, P Gogas, H Stathopoulos, G Razis, E Bafaloukos, D Skarlos, D

Citation: G. Fountzilas et al., Weekly paclitaxel as first-line chemotherapy and trastuzumab in patients with advanced breast cancer - A Hellenic Cooperative Oncology Group phase IIstudy, ANN ONCOL, 12(11), 2001, pp. 1545-1551

Authors: Razis, E Dimopoulus, AM Bafaloukos, D Papadimitriou, C Kalogera-Fountzila, A Kalofonos, H Briassoulis, E Samantas, E Keramopoulos, A Pavlidis, N Kosmidis, P Fountzilas, G

Citation: E. Razis et al., Dose-dense sequential chemotherapy with epirubicin and paclitaxel in advanced breast cancer, CANCER INV, 19(2), 2001, pp. 137-144

Authors: Fountzilas, G Papadimitriou, C Dafni, U Bafaloukos, D Skarlos, D Moulopouos, LA Razis, E Kalofonos, HP Aravantinos, G Briassoulis, E Papakostas, P Abela, K Gogas, E Kosmidis, P Pavlidis, N Dimopoulos, MA

Citation: G. Fountzilas et al., Dose-dense sequential chemotherapy with epirubicin and paclitaxel versus the combination, as first-line chemotherapy, in advanced breast cancer: A randomized study conducted by the Hellenic Cooperative Oncology Group, J CL ONCOL, 19(8), 2001, pp. 2232-2239